After an outbreak in December 2019 in Wuhan, Hubei Province of China, coronavirus disease 2019 (COVID-19) has rapidly become a pandemic. The 2019 novel coronavirus (2019 nCov), now called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causes a wide spectrum of illness and patients with underlying comorbidities have a high mortality. Here we present a 49-year-old male patient with comorbid conditions who presented with fever, cough, myalgia and shortness of breath for five days with likely exposure to a COVID-19 contact. A computed tomography scan of the thorax revealed multifocal bilateral ground-glass lung opacities with areas of subpleural sparing. He tested positive for SARS-CoV-2 by nucleic acid amplification. Hydroxychloroquine therapy was started, and the patient responded favorably with improvement of symptoms. Early diagnosis and self-isolation or quarantine remain key to stemming the tide of the contagion as there is a real risk of the healthcare system being overwhelmed.
【저자키워드】 COVID-19, Hydroxychloroquine, Pneumonia, 2019-nCoV, 2019 novel coronavirus, ground-glass opacity, Wuhan, CoV, sars-cov-2 (severe acute respiratory syndrome coronavirus -2), multifocal, 【초록키워드】 coronavirus disease, SARS-CoV-2, coronavirus, pandemic, therapy, quarantine, Diagnosis, Comorbidity, risk, cough, Symptoms, China, Computed tomography, outbreak, Fever, male, Patient, nucleic acid amplification, Contact, Contagion, myalgia, Healthcare system, Shortness of breath, Self-isolation, Thorax, acute respiratory syndrome, Lung Opacity, high mortality, positive, FIVE, tested, the patient, cause, comorbid condition, subpleural,